Summary - A new market study, titled “Global Ablation Catheters Market - 2019-2026” has been featured on
Global Ablation Catheters Market Overview
The global ablation catheters market is expected to grow at a CAGR of XX% to reach a market value of USD XX million by 2026.
Ablation is the removal of a part of biological tissue, usually by surgery. Surface ablation of the skin (dermabrasion) is carried out by lasers (laser ablation), chemicals (chemoablation), by freezing (cryoablation), or by electricity (fulguration). Catheter ablation is a minimally invasive procedure in which a physician advances a flexible thin tube (catheter) through the blood vessels of the heart to ablate (stop) abnormal electrical pathways (signals) in the heart tissue.
ALSO READ:
Global Ablation Catheters Market – Market Dynamics
The global market for ablation catheters is primarily driven by the rise in prevalence of cardiac arrhythmia with the rise in the elderly population. The rising prevalence of Coronary Artery Disease (CAD) is one of the major driving factor leading to growth of the ablation catheters market. The CAD is the most prominent cause of death globally and is expected to lead during the forecast period. According to WHO, it is estimated that CAD will be responsible for a total of 11.1 million deaths, globally by 2020. In Europe, one in every seven European women dies of CAD, and in case of men, the percentage varies from 16% to 25%.
In addition to its impact on mortality, CAD is a leading cause of morbidity and loss of quality of life. This makes CAD a major public health problem, exerting heavy economic costs.
Advances in healthcare led companies to develop innovative ablation catheters that help reduce the procedural duration and offer better ablation than previous generation devices. Next-generation advanced devices are safe, efficient, and cost-effective and provide better outcomes. For instaces, Boston Scientific’s IntellaTip MiFi XP Temperature Ablation Catheter is one such device that uses MicroFidelity (MiFi) sensor technology with embedded mini-electrodes on the tip.
However, the risk associated with ablation procedures, the high cost of ablation procedures, stringent regulatory approval process and lack of skilled electrophysiologists may hinder the market progress.
Global Ablation Catheters Market – Segment Analysis
By Product type, the ablation catheters market is segmented into multielectrode ablation catheters and single point ablation catheters. The multielectrode ablation catheters share the most established market due to its prominent advantages reduce the duration of ablation procedures, improve the making of contiguous lesions, and prevent certain complications associated with unipolar RF energy.
On the basis of procedures, the supraventricular tachycardia ablation holds the major share in terms of volume for the year 2018, followed by Atrial fibrillation ablation. Supraventricular tachycardia is the improper electrical activity that originates at or above the atrioventricular node in the heart. For instance, the Wolff-Parkinson-White syndrome can short circuit the heart's electrical system due to the abnormal electrical connection between the atria and ventricles, causing this condition.
Global Ablation Catheters Market– Geographical Analysis
North America market accounted for the largest share in the ablation catheters market. It is attributed to the increasing prevalence of patients with chronic illnesses along with the rapid adoption of minimal-invasive therapies. To reduce healthcare expenditure and provide improved medical outcomes, companies such as Biosense Webster, Boston Scientific, and Medtronic, are developing innovative ablation catheters. For instance, in April 30, 2018, LuxCath LLC a medical technology company addresses persistent unmet needs in the catheter ablation treatment of cardiac arrhythmias, has showcased the OmniView light-guided ablation catheter an only technology which can see into tissue during cardiac ablation and assess catheter-tissue contact and lesion progression in real time. The growing research funding and technological advancements are other factors that help the market see profitable growth.
The Asia Pacific is expected to be the fastest growing share owing it to its vast and diverse patient pool, development in healthcare infrastructure and improving economic conditions, in urbanization & disposable income, and growing awareness about ablation catheters.
Global Ablation Catheters Market– Competitive Analysis
Key players are adopting strategies such as product launches, mergers and acquisitions, partnerships, and regional expansion to stand out as strong competitors in the market. New product launches along with increased focus on R&D are other ways the leading players improve their market presence.
In January 21, 2019, Abbott received U.S. Food and Drug Administration (FDA) approval of the TactiCath Contact Force Ablation Catheter, Sensor Enabled, a new ablation catheter designed to help physicians accurately and effectively treat atrial fibrillation (AFib)
In February 2019, Biosense Webster enrolled and treated the first patient in its U.S. Investigational Device Exemption (IDE) study evaluating the company’s QDot Micro radiofrequency (RF) ablation catheter in the treatment of symptomatic drug-refractory paroxysmal atrial fibrillation (AF)
In June 2018, Philips Healthcare had an agreement to acquired EPD Solutions, a provider of image-guidance in catheter ablation procedures for cardiac arrhythmias, for $292 million Euros
In 2015, AtricCure acquired nContact, a privately-held developer of innovative cardiac ablation solutions.
Why Purchase the Report?
- Visualize the composition of the global ablation catheters market across each indication, in terms of type and treatment options, highlighting the key commercial assets and players.
- Identify commercial opportunities in global ablation catheters market by analyzing trends and co-development deals.
- Excel data sheet with thousands of data points of the global ablation catheters market - level 4/5 segmentation.
- PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
- Product mapping in excel for the key products of all major market players
Target Audience:
- Equipment Suppliers/ Buyers
- Service Providers/ Buyers
- Industry Investors/Investment Bankers
- Education & Research Institutes
- Research Professionals
- Emerging Companies
- Manufacturers
https://www.wiseguyreports.com/reports/3792049-global-ablation-catheters-market-2019-2026
About Us:Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +162-826-80070 (US)
Ph: +44 203 500 2763 (UK)
Atrial Fibrillation Market Research Report: By Type (Paroxysmal and Others), by Treatment (Medications, Non-Surgical Procedures, and Surgical Procedures), by End-User (Hospitals, Electrophysiology Labs, and Ambulatory Surgical Centers)—Forecast till 2023Atrial Fibrillation Market AnalysisGlobal atrial fibrillation market is poised to have a promising growth over the predicted years (2017-2023).
There are some who may have no symptoms thus being unaware of the condition till it is discovered at the time of a physical examination, while there are others that may experience different signs and symptoms.
Damage or abnormalities to the heart’s structure are the common causes resulting in atrial fibrillation.
Some of its possible causes include sleep apnea, stress due to surgery, pneumonia or other illness, viral infections, previous heart surgery, lung diseases, sick sinus syndrome, exposure to stimulants namely alcohol, tobacco, caffeine or medications, overactive thyroid gland, heart defects a person is born with, abnormal heart valves, coronary artery disease, heart attacks and high blood pressure.There are plentiful factors that is boosting the growth of the atrial fibrillation market.
These factors as per the Market Research Future (MRFR) report include increasing occurrence of atrial fibrillation amid the geriatric population, advancements in technology, increase in penchant for catheter ablation to treat cardiac arrhythmia, increasing incidences of health cases mainly hypertension, rheumatic fever, obesity and diabetes, various lifestyle illnesses, sedentary occupations and eating habits that may cause cardiac issues.
Under surgical devices segment, EP ablation catheters will have the maximum share in the market over the predicted years.Based on applications, the atrial fibrillation market is segmented into ambulatory wards, well-established hospitals, high-tech medical centers, electrophysiology laboratories, and cardiac centers.
The research includes several basic steps which we will scrutinize later.
Audience analysis benefits Helps define the functionality setWhen you already have chosen the group of people that theoretically will want to pay for your mobile app, you can make a development plan, which includes the list of features of your future application.
The application needs to include the ability to send photos, videos and voice messages.
There are lots of options and when you understand the needs and preferences of your target audience, you can easily pick the one, that will bring you the most money and wont annoy users.
For instance, if you create an app for young mothers, the ads about baby products wont irritate customers and will interest them.
Understanding of who is your target audience, how old he or she is, where they live, what their income is, you can see what adjustments are needed to be done to launch a perfect software solution for your customer.
The report “Cardiac Mapping Market by Product (Contact Mapping Systems (Electroanatomical Mapping, Basket Catheter Mapping), Non-contact Mapping Systems), Indication (Atrial Fibrillation, Atrial Flutter, AVNRT), Region – Global Forecast to 2024″, the Cardiac Mapping System Market is expected to reach USD 2.1 billion by 2024 from USD 1.4 billion in 2019, at a CAGR of 8.7%.The Growth in the cardiac mapping industry is driven primarily by factors such as new entrants in the market, growing investments, funds, and grants, increasing incidence of target diseases, and growth in the geriatric population.Market Size Estimation;Both top-down and bottom-up approaches were used to estimate and validate the total size of the cardiac mapping market.
The research methodology used to estimate the market size includes the following:– The key players in the industry and markets have been identified through extensive secondary research– The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes– All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sourcesRequest Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=89853405Atrial fibrillation is the primary application areas of the global cardiac mapping marketThe market is segmented into atrial fibrillation, atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), other arrhythmias.
The atrial fibrillation segment estimated to command the largest share of the market in 2019, and this segment is also projected to register the highest CAGR owing to the rise in incidences of AF worldwide and the subsequent increase in the ablation procedures.Geographical View in-detailed:North America held the largest share of the market in 2019 and is projected to continue to do so during the forecast period.
Factors such as the increase in approval rate of mapping systems and clinical trials validating cardiac mapping systems in the US, high incidence of CVDs, growing focus of government organizations on providing funding for research, and increasing geriatric population in Canada are driving the North American cardiac mapping market.Key Market Players;The major vendors in the cardiac mapping market include Biosense Webster (US), Abbott (US), and Boston Scientific Corporation (US).
These leading players offer a strong suit of products for cardiac mapping and have a broad geographic presence.
The other players in this market include Medtronic (Ireland), MicroPort Scientific Corporation (China), EP Solutions SA (Switzerland), Acutus Medical (US), Koninklijke Philips N.V. (Royal Philips) (Netherlands), Lepu Medical (China), BIOTRONIK (Germany), AngioDynamics (US), BioSig Technologies (US), APN Health (US), CoreMap (US), Kardium (Canada), Catheter Precision (US), and Epmap-System (Germany).Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=89853405Biosense Webster (US) held the dominant position in the cardiac mapping market in 2018.
By launching a mobile application, you become part of a global market estimated in the billions of dollars.
Define the target audience for a new mobile app based on its type
Before you define your target audience, consider the category your application belongs to, since this can significantly narrow the search and help you to identify your ideal target customer from the first attempt.
- Entertainment
- Travel
- Business
- Social applications
- Food
- Sports
- Education
- News
- Shopping
- Games
